- Tumor Necrosis Rate to Peak Serum Level of MTX in the Preoperative Chemotherapy of Osteosarcoma
-
Son JW, Kim JD, Jung SH, Jaug JH, Lee SM, Kim C, Cha JS
- KMID: 2399038
- J Korean Orthop Assoc.
- 2003 Aug;38(4):372-377.
PURPOSE: High dose methotrexate (HDMTX) dramatically increases survival rate, which is related to the histologic response of tumornecrosis rate in the treatment of osteosarcoma. But, the study of tumor necrosis... -
- CITED
-
- Close
- SHARE
-
- Close
